Two of the leading healthcare technology providers, Philips and GE recently announced their almost simultaneous entry into the fast-growing Indian home healthcare market. Both these companies have launched their sleep therapy solutions and respiratory care solutions in India.Philips added the Respironics product categories in obstructive sleep apnea management and home respiratory care to its existing healthcare product portfolio in India. Philips’ ‘in-hospital’ position was also strengthened through the introduction of Respironics’ strong non-invasive ventilation and respiratory monitoring products for hospitals and clinics. With this launch, India becomes the first country where Philips Respironics portfolio has been formally launched post the company’s global acquisition of Respironics in 2008. On the other hand, GE’s home health solutions are added through its acquisition of Vital Signs Inc. and its subsidiary Breas Medical AB. While Vital Signs is a global provider of medical products applicable to a wide range of care areas such as anesthesia, respiratory, sleep therapy and emergency medicine, Breas Medical AB developed the ‘iSleep’ (sleep apnea management solution) and Vivo series of respiratory care solutions. Both Vital Signs and Breas Medical AB’s products will highly complement GE Healthcare’s leading anesthesia delivery, patient monitoring and acute respiratory offerings.